London & Capital Asset Management LTD Pfizer Inc Transaction History

London & Capital Asset Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $282,162 - $331,040	-8,887 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $39,065 - $47,392	-1,297 Reduced 12.74%	8,887 $291,000
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $5,270 - $7,530	-195 Reduced 1.88%	10,184 $332,000
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $50,038 - $56,787	-1,520 Reduced 12.77%	10,379 $407,000
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $28,818 - $37,369	887 Added 8.05%	11,899 $428,000
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $15,679 - $17,604	-424 Reduced 3.71%	11,012 $477,000
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $439,942 - $501,582	11,436 New	11,436 $499,000

3,247

3.72B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of London & Capital Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on London & Capital Asset Management LTD with notifications on news.